Lena Öhman
Göteborgs universitet
H-index: 45
Europe-Sweden
Top articles of Lena Öhman
P296 Preclinical protein signatures in blood predict Crohn's disease and Ulcerative colitis several years before the diagnosis
Journal of Crohn's and Colitis
2024/1/1
Predictors of Symptoms Trajectories in Newly Diagnosed Ulcerative Colitis: A 3-Year Follow-up Cohort Study
Journal of Crohn's and Colitis
2024/3/29
Livia Guadagnoli
H-Index: 5
Lena Öhman
H-Index: 32
Temporal stability of fecal metabolomic profiles in irritable bowel syndrome
Neurogastroenterology & Motility
2024/1/19
Otto Savolainen
H-Index: 13
Lena Öhman
H-Index: 32
Depressive symptoms in ulcerative colitis and Crohn's disease-differences in improvement at 1 year follow-up
2024
P219 Prognostic potential of mucosal proteins in Ulcerative Colitis
Journal of Crohn's and Colitis
2024/1/1
Fecal Supernatants from Patients with Crohn’s Disease Induce Inflammatory Alterations in M2 Macrophages and Fibroblasts
Cells
2023/12/27
DOP11 A novel diagnostic serum protein signature for paediatric Inflammatory Bowel Disease: A discovery and validation study in two independent inception cohorts
Journal of Crohn's and Colitis
2023/2/1
DOP14 Identification and validation of a lipidomic signature as a novel diagnostic biomarker of paediatric Inflammatory Bowel Disease
Journal of Crohn's and Colitis
2023/2/1
P154 A novel serum protein signature as biomarker for Inflammatory Bowel Disease: A diagnostic performance and prediction modelling study using data from two independent …
Journal of Crohn's and Colitis
2023/2/1
Fecal Biomarkers of Neutrophil and Eosinophil Origin Reflect the Response to Biological Therapy and Corticosteroids in Patients With Inflammatory Bowel Disease
Clinical and Translational Gastroenterology
2023
Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative Colitis
Clinical and Experimental Gastroenterology
2022/12/31
Fecal luminal factors from patients with gastrointestinal diseases alter gene expression profiles in Caco-2 cells and colonoids
International Journal of Molecular Sciences
2022/12/7
gluten‐free but not pain‐free in IBS—authors' reply
2022/12
Lena Öhman
H-Index: 32
Randomised controlled trial: effects of gluten‐free diet on symptoms and the gut microenvironment in irritable bowel syndrome
Alimentary pharmacology & therapeutics
2022/11
Lena Öhman
H-Index: 32
Differences in Metabolite Composition of Aloe barbadensis Mill. Extracts Lead to Differential Effects on Human Blood T Cell Activity In Vitro
Molecules
2022/10/6
Otto Savolainen
H-Index: 13
Lena Öhman
H-Index: 32
Fecal luminal factors from patients with irritable bowel syndrome induce distinct gene expression of colonoids
Neurogastroenterology & Motility
2022/10
Otto Savolainen
H-Index: 13
Lena Öhman
H-Index: 32
Randomised clinical trial and meta‐analysis: mesalazine treatment in irritable bowel syndrome—effects on gastrointestinal symptoms and rectal biomarkers of immune activity
Alimentary Pharmacology & Therapeutics
2022/9
Faecal biomarkers of neutrophil and eosinophil origin reflect the response to biological therapy and corticosteroids in patients with IBD
Clinical and Translational Gastroenterology
2022/5/13
Health-related quality of life in patients with long-standing ulcerative colitis in remission
2024/1/1
Predictors of symptom-specific treatment response to dietary interventions in irritable bowel syndrome
Nutrients
2022/1/17
